SHR2554

Clinical trials for SHR2554 explained in plain language.

Never miss a new study

Get alerted when new SHR2554 trials appear

Sign up with your email to follow new studies for SHR2554, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New combo aims to cut relapse in tough leukemia cases

Disease control Not yet recruiting

This study tests whether adding two drugs (SHR2554 and azacitidine) before a stem cell transplant can lower the chance of leukemia coming back. It includes 160 people aged 15-60 with high-risk or hard-to-treat acute leukemia or myelodysplastic syndromes. Participants are randomly…

Matched conditions: SHR2554

Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control

Last updated May 08, 2026 12:03 UTC

SHR2554

Get alerted when new SHR2554 trials appear

New combo aims to cut relapse in tough leukemia cases